デフォルト表紙
市場調査レポート
商品コード
1771575

肥満向けデジタルヘルス市場の規模、シェア、動向分析レポート:コンポーネント別、最終用途別、地域別、セグメント予測、2025~2033年

Digital Health For Obesity Market Size, Share & Trends Analysis Report By Component, By End-use, By Region, And Segment Forecasts, 2025 - 2033


出版日
ページ情報
英文 130 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
肥満向けデジタルヘルス市場の規模、シェア、動向分析レポート:コンポーネント別、最終用途別、地域別、セグメント予測、2025~2033年
出版日: 2025年06月13日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

肥満向けデジタルヘルス市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の肥満向けデジタルヘルスの市場規模は2033年までに3,928億9,000万米ドルに達し、2025~2033年までのCAGRは24.0%を記録すると推定されています。

19億人以上の成人が罹患している世界の肥満率の上昇が、体重管理ソリューションに対する大きな市場需要を生み出しています。座りっぱなしの習慣や不健康な食事の選択など、ライフスタイルの変化がこの成長に大きく寄与しています。糖尿病や心血管疾患など、肥満に関連する健康リスクに対する意識の高まりが、効果的な介入策を求める個人を後押ししています。さらに、技術の進歩とデジタルヘルスソリューション、パーソナライズされた食事指導アプリ、ウェアラブルデバイスの台頭により、体重管理のために技術を利用する人が増えており、市場の成長をさらに後押ししています。健康意識、技術革新、効果的な体重管理ソリューションに対する緊急のニーズが交差していることが、市場の成長を後押ししています。

さらに、肥満市場におけるデジタルヘルスソリューションの成長は、健康意識の高まりとともに、肥満と関連する健康状態の有病率が上昇していることに起因しています。人工知能(AI)や機械学習(ML)などの先進技術を取り入れることは、市場拡大にさらに貢献すると予想されます。同市場では、iOSやAndroidなど様々なOS上でアプリケーションを提供する様々な減量アプリが登場しています。これらのアプリは、ライフスタイルのモニタリング、食事追跡、体重管理、運動モニタリングなど、さまざまな側面に対応しています。世界の肥満動向は増加の一途をたどっており、減量アプリの需要も高まっています。

さらに、肥満向けデジタルヘルス市場では、COVID-19パンデミックの影響により、遠隔患者管理(RPM)の受け入れが増加しています。便利で利用しやすいツールを導入することで、治療への障害が減少し、頻繁な対面診療の必要性がなくなりました。RPMによって、ヘルスケア専門家は一貫して患者をモニターし、タイムリーな遠隔支援を提供することができるようになり、移動が困難な人や多忙なスケジュールの人に有利であることが証明されました。この費用対効果に優れた便利なアプローチは、効果的な体重管理を可能にし、より高い関与と個別化ヘルスケアを促進します。

同市場で事業を展開する主要企業は、製品形成とリーチの拡大に重点を置き、提携、M&A、パートナーシップ、製品発売などの戦略を採用しています。例えば、2023年10月、医療情報整理のための人工知能活用に特化した新興企業であるMendel.aiは、AI搭載プラットフォームであるHypercubeを発表しました。この革新的なシステムは、構造化テキストデータと非構造化テキストデータの両方を統合し、分析を民主化し、ユーザーが自由テキストで質問を投げかけることを可能にします。Hypercubeはその後、特定の患者データから導き出された結果を提供し、医療情報分析のアクセシビリティと効率を高めます。2023年5月、Noom, Inc.は、病気としての肥満と闘うために設計されたNoom Medを発表しました。Noom Medは、さまざまな遠隔医療サービスとNoomの個別化された心理学的ツールを統合し、持続的な減量を促進します。このプログラムは、同社の消費者向けソリューションとして広く利用されているNoom Weightの拡張版であり、持続的な減量への障害を克服するために、心理学的原則、人間支援、テクノロジーを活用して患者に力を与えるものです。

肥満向けデジタルヘルス市場レポートのハイライト

  • コンポーネント別では、サービスセグメントが2024年に最大の市場収益シェアを占めました。この成長は、設置、メンテナンス、トレーニング、その他のサービスに対する需要の高まりによるものです。
  • 最終用途別では、患者セグメントが2024年に最大の市場シェアを占め、予測期間中に最も速いCAGRで成長すると予測されています。
  • 北米は、2024年に37.7%以上の収益シェアで市場を独占しました。これは、ヘルスケアIT支出の増加、適切なデジタルインフラの利用可能性、技術の進歩、新興企業の台頭によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 肥満向けデジタルヘルス市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助的な市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 肥満市場分析ツールのためのデジタルヘルス
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
  • 市場における新たな技術動向
  • 市場におけるテクノロジーの情勢
  • ケーススタディ分析
  • 国別の規制と償還シナリオ
  • バリューチェーン分析
  • 市場資金調達/投資シナリオ
    • ベンチャーキャピタル(VC)の取引活動
    • 2024年のデジタルヘルスVC取引トップ10
    • 年間株式資金調達と取引
    • 四半期ごとの株式資金調達と取引
    • 世界の地域別の四半期資金調達と取引
    • 世界の地域別の四半期取引の割合
    • 投資家グループ別の四半期取引の割合
    • 年間平均および中央値の取引規模
    • 世界の地域別の年間平均取引規模
    • 投資家グループ別の年間平均取引規模
    • 年間メガラウンドの資金調達と取引
    • 四半期ごとの資金調達とメガラウンドからの取引
    • 世界の地域別の四半期メガラウンド資金調達と取引
    • 世界の地域別の四半期メガラウンド取引
    • 四半期ごとのメガラウンドの資金調達の割合
    • 四半期ごとの株式取引
    • 取引段階別の年間取引割合
    • 取引段階別の四半期ごとの地域取引シェア
    • 取引段階別の年間資金調達額の中央値
    • 四半期ごとのシード/エンジェル取引
    • 四半期ごとのシリーズA取引
    • 四半期ごとのシリーズB取引
    • 四半期ごとのシリーズC取引
    • 四半期ごとのシリーズD取引
    • 四半期ごとのシリーズE+取引
  • デジタルヘルスにおけるユニコーン企業の資金調達動向
    • 四半期ごとの新規および合計ユニコーン
    • 世界の地域別の四半期ごとの新規ユニコーン企業数と合計企業数
    • 世界の地域別の四半期ごとの新規ユニコーン企業数
    • 四半期ごとのユニコーン評価額
  • デジタルヘルス市場における出口動向
    • 年間退職金
    • 四半期ごとの出口動向
    • 世界の地域別の四半期ごとの退職率
    • 四半期ごとのM&A出口動向
    • 四半期ごとのIPO
  • デジタルヘルス情勢における主要投資家の分析
    • 四半期ごとの企業数別の投資家
    • 四半期ごとの企業数別のVC
    • 四半期ごとの企業数別のコーポレートVC(CVC)
  • デジタルヘルス市場における主要な投資地域動向
    • 米国の動向
    • アジアの動向
    • 中国
    • 日本
    • 欧州の動向
    • 英国

第4章 肥満向けデジタルヘルス市場:コンポーネント別の推定・動向分析

  • 定義と範囲
  • コンポーネント別の市場シェア、2024年および2033年
  • セグメントダッシュボード
  • 肥満向けデジタルヘルス市場:コンポーネント別の展望
  • ソフトウェア
  • ハードウェア
  • サービス

第5章 肥満向けデジタルヘルス市場:最終用途別の推定・動向分析

  • 定義と範囲
  • 最終用途別の市場シェア、2024年および2033年
  • セグメントダッシュボード
  • 肥満向けデジタルヘルス市場:最終用途別の展望
  • 患者
  • 医療従事者
  • 医療支払者
  • その他

第6章 肥満向けデジタルヘルス市場:地域別の推定・動向分析

  • 地域別の市場シェア分析、2024年および2033年
  • 地域別の市場ダッシュボード
  • 世界の地域別市場のスナップショット
  • 地域別のSWOT分析
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • シンガポール
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
    • イノベーター
  • 主要企業の市況分析、2024年
  • List of Companies
    • WW International
    • MyFitnessPal Inc.
    • Teladoc
    • FitnessKeeper
    • Healthify (My Diet Coach)
    • PlateJoy
    • Tempus
    • Fitbit, Inc.
    • Noom
    • WellDoc
    • Sidekick Health
    • BioAge Labs
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 4 North America digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 5 U.S. digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 6 U.S. digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 7 Canada digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 8 Canada digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Europe digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 10 Europe digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 11 Europe digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Germany digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 13 Germany digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 14 UK digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 15 UK digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 16 France digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 17 France digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 18 Italy digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 19 Italy digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Spain digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 21 Spain digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 22 Denmark digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 23 Denmark digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Sweden digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 25 Sweden digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Norway digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 27 Norway digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Asia Pacific digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 31 China digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 32 China digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Japan digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 34 Japan digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 35 India digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 36 India digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 37 South Korea digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 38 South Korea digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Australia digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 40 Australia digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Singapore digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 42 Singapore digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Latin America digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 44 Latin America digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 45 Latin America digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 46 Brazil digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 47 Brazil digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Mexico digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 49 Mexico digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Argentina digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 51 Argentina digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 52 MEA digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 53 MEA digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 54 MEA digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 55 South Africa digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 56 South Africa digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Saudi Arabia digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 58 Saudi Arabia digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 59 UAE digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 60 UAE digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Kuwait digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 62 Kuwait digital health for obesity market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Digital health for obesity market: market outlook
  • Fig. 9 Digital health for obesity competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Digital health for obesity market driver impact
  • Fig. 13 Digital health for obesity market restraint impact
  • Fig. 14 Digital health for obesity market: Component movement analysis
  • Fig. 15 Digital health for obesity market: Component outlook and key takeaways
  • Fig. 16 Software market estimates and forecast, 2021 - 2033
  • Fig. 17 Hardware market estimates and forecast, 2021 - 2033
  • Fig. 18 Services market estimates and forecast, 2021 - 2033
  • Fig. 19 Digital health for obesity market: End use movement analysis
  • Fig. 20 Digital health for obesity market: End use outlook and key takeaways
  • Fig. 21 Patients market estimates and forecast, 2021 - 2033
  • Fig. 22 Providers market estimates and forecast, 2021 - 2033
  • Fig. 23 Payers market estimates and forecast, 2021 - 2033
  • Fig. 24 Others market estimates and forecast, 2021 - 2033
  • Fig. 25 Global digital health for obesity market: Regional movement analysis
  • Fig. 26 Global digital health for obesity market: Regional outlook and key takeaways
  • Fig. 27 Global digital health for obesity market share and leading players
  • Fig. 28 North America: SWOT
  • Fig. 29 Europe SWOT
  • Fig. 30 Asia Pacific SWOT
  • Fig. 31 Latin America SWOT
  • Fig. 32 MEA SWOT
  • Fig. 33 North America, by country
  • Fig. 34 North America
  • Fig. 35 North America market estimates and forecasts, 2021 - 2033
  • Fig. 36 U.S.
  • Fig. 37 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 38 Canada
  • Fig. 39 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 40 Europe, by country
  • Fig. 41 Europe
  • Fig. 42 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 43 UK
  • Fig. 44 UK market estimates and forecasts, 2021 - 2033
  • Fig. 45 Germany
  • Fig. 46 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 47 France
  • Fig. 48 France market estimates and forecasts, 2021 - 2033
  • Fig. 49 Italy
  • Fig. 50 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 51 Spain
  • Fig. 52 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 53 Denmark
  • Fig. 54 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 55 Sweden
  • Fig. 56 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 57 Norway
  • Fig. 58 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 59 Asia Pacific, by country
  • Fig. 60 Asia Pacific
  • Fig. 61 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 62 China
  • Fig. 63 China market estimates and forecasts, 2021 - 2033
  • Fig. 64 Japan
  • Fig. 65 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 66 India
  • Fig. 67 India market estimates and forecasts, 2021 - 2033
  • Fig. 68 Singapore
  • Fig. 69 Singapore market estimates and forecasts, 2021 - 2033
  • Fig. 70 South Korea
  • Fig. 71 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 72 Australia
  • Fig. 73 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 74 Latin America, by country
  • Fig. 75 Latin America
  • Fig. 76 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 77 Brazil
  • Fig. 78 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 79 Mexico
  • Fig. 80 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 81 Argentina
  • Fig. 82 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 83 Middle East and Africa, by country
  • Fig. 84 Middle East and Africa
  • Fig. 85 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 86 South Africa
  • Fig. 87 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 88 Saudi Arabia
  • Fig. 89 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 90 UAE
  • Fig. 91 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 92 Kuwait
  • Fig. 93 Kuwait market estimates and forecasts, 2021 - 2033
目次
Product Code: GVR-4-68040-255-7

Digital Health For Obesity Market Growth & Trends:

The global digital health for obesity market size is estimated to reach USD 392.89 billion by 2033, registering a CAGR of 24.0% from 2025 to 2033, according to a new report by Grand View Research, Inc. Rising global obesity rates, with over 1.9 billion adults affected, have created a substantial market demand for weight management solutions. Lifestyle changes, including sedentary habits and unhealthy dietary choices, contribute significantly to this growth. The increasing awareness of obesity-related health risks, such as diabetes and cardiovascular diseases, propels individuals toward seeking effective interventions. In addition, advancements in technology and the emergence of digital health solutions, personalized dietary guidance apps, and wearable devices, further drive market growth as people increasingly turn to technology for managing their weight. The intersection of health consciousness, technological innovation, and the urgent need for effective weight management solutions collectively fuels the market growth.

Furthermore, the growth of digital health solutions in obesity market can be attributed to a rising prevalence of obesity and associated health conditions, alongside growing health awareness. Incorporating advanced technologies such as artificial intelligence (AI) and machine learning (ML) is anticipated to further contribute to market expansion. Various weight loss apps are being launched in that market that offer applications on various operating systems, including iOS, Android, and others. These apps cater to various aspects such as lifestyle monitoring, diet tracking, weight management, exercise monitoring, and more. As obesity rates continue to rise globally, there is an increasing demand for weight loss apps, and companies are leveraging this trend to their advantage.

Furthermore, the digital health obesity market has witnessed increased acceptance of remote patient management (RPM) due to the impact of the COVID-19 pandemic. Implementing convenient and accessible tools has diminished obstacles to care, eliminating the necessity for frequent in-person visits. RPM allows healthcare professionals to consistently monitor patients and provide timely remote assistance, proving advantageous for individuals with limited mobility or hectic schedules. This cost-effective and convenient approach enables effective weight management and promotes heightened engagement and personalized healthcare.

The major players operating in the market are adopting strategies such as collaborations, mergers and acquisitions, and partnerships, product launches, with a major focus on enhancing product formation and reach. For instance, in October 2023, Mendel.ai, a startup specializing in the utilization of artificial intelligence for organizing medical information, unveiled Hypercube, an AI-powered platform. This innovative system integrates both structured and unstructured text data, democratizing analytics and enabling users to pose questions in free text. Hypercube then provides outcomes derived from specific patient data, enhancing accessibility and efficiency in medical information analysis. In May 2023, Noom, Inc. introduced Noom Med, designed to combat obesity as a disease. Noom Med integrates a range of telehealth services with Noom's personalized psychological tools to facilitate enduring weight loss. This program, an augmentation of Noom Weight, the company's widely used consumer-facing solution, utilizes psychological principles, human assistance, and technology to empower patients in overcoming obstacles to sustained weight loss.

Digital Health For Obesity Market Report Highlights:

  • Based on component, the services segment accounted for the largest market revenue share in 2024. This growth can be attributed to the growing demand for installation, maintenance, training, and other services.
  • Based on end-use, the patient segment accounted with the largest market share in 2024 and is anticipated to witness at the fastest CAGR over the forecast period.
  • North America dominated the market in 2024 with a revenue share of over 37.7%, owing to growing healthcare IT expenditure, availability of adequate digital infrastructure, technological advancements, the emergence of startups.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Component
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component outlook
    • 2.2.2. End Use outlook.
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Digital Health for Obesity Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing adoption of digital technology in obesity care
      • 3.2.1.2. Increasing use of artificial intelligence (AI), internet of things (IoT), and big data
      • 3.2.1.3. Growing adoption of mobile health applications and technologies
      • 3.2.1.4. Increasing burden of mental disorders
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Privacy and security concerns
      • 3.2.2.2. Lack of healthcare infrastructure
  • 3.3. Digital Health for Obesity Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Emerging Technological Trends in the Market
  • 3.5. Technology Landscape in the Market
  • 3.6. Case Study Analysis
  • 3.7. Regulatory and Reimbursement Scenario, by Country
  • 3.8. Value Chain Analysis
  • 3.9. Market Funding/Investment Scenario
    • 3.9.1. Venture capital (VC) deal activity
    • 3.9.2. Top 10 digital health VC deals in 2024
    • 3.9.3. Annual equity funding & deals
    • 3.9.4. Quarterly equity funding & deals
    • 3.9.5. Quarter funding & deals by global region
    • 3.9.6. Percent of quarterly deals by global region
    • 3.9.7. Percent of quarterly deals by investor group
    • 3.9.8. Annual average & median deal size
    • 3.9.9. Annual median deal size by global region
    • 3.9.10. Annual median deal size by investor group
    • 3.9.11. Annual mega-round funding & deals
    • 3.9.12. Quarterly funding & deals from mega-rounds (deals worth usd 100 million+)
    • 3.9.13. Quarter mega-round funding & deals by global region
    • 3.9.14. Quarterly mega-round deals by global region
    • 3.9.15. Quarterly mega-rounds as percentage of funding
    • 3.9.16. Quarter top equity deals
    • 3.9.17. Annual percentage of deals by deal stage
    • 3.9.18. Quarter regional deal shares by deal stage
    • 3.9.19. Annual median funding by deal stage
    • 3.9.20. Quarter top seed/angel deals
    • 3.9.21. Quarter top series A deals
    • 3.9.22. Quarter top series B deals
    • 3.9.23. Quarter top series C deals
    • 3.9.24. Quarter top series D deals
    • 3.9.25. Quarter top series E+ deals
  • 3.10. Unicorn Funding Trends in Digital Health
    • 3.10.1. Quarterly new & total unicorns (private companies valued at USD 1 billion+)
    • 3.10.2. Quarter new & total unicorns by global region
    • 3.10.3. Quarterly new unicorns by global region
    • 3.10.4. Quarter top unicorns by valuation
  • 3.11. Exit Trends in Digital Health Market
    • 3.11.1. Annual exits
    • 3.11.2. Quarterly exits
    • 3.11.3. Percent of quarterly exits by global region
    • 3.11.4. Quarter top M&A exits
    • 3.11.5. Quarter top IPOs
  • 3.12. Key Investors Analysis in the Digital Health Landscape
    • 3.12.1. Quarter top investors by company count
    • 3.12.2. Quarter top VCs by company count
    • 3.12.3. Quarter top corporate VCs (CVCs) by company count
  • 3.13. Key Investment Geographic Trends in Digital Health Market
    • 3.13.1. U.S. Trends
      • 3.13.1.1. Annual funding & deals
      • 3.13.1.2. Quarterly funding & deals
      • 3.13.1.3. Annual percentage of deals by deal stage
      • 3.13.1.4. Quarter top equity deals
      • 3.13.1.5. Annual exits
      • 3.13.1.6. Quarterly exists
      • 3.13.1.7. Quarter top investors by company count
    • 3.13.2. Asia Trends
      • 3.13.2.1. Annual funding & deals
      • 3.13.2.2. Quarterly funding & deals
      • 3.13.2.3. Annual percentage of deals by deal stage
      • 3.13.2.4. Quarter top equity deals
      • 3.13.2.5. Annual exits
      • 3.13.2.6. Quarterly exists
      • 3.13.2.7. Quarter top investors by company count
    • 3.13.3. China
    • 3.13.4. Japan
    • 3.13.5. Europe Trends
      • 3.13.5.1. Annual funding & deals
      • 3.13.5.2. Quarterly funding & deals
      • 3.13.5.3. Annual percentage of deals by deal stage
      • 3.13.5.4. Quarter top equity deals
      • 3.13.5.5. Annual exits
      • 3.13.5.6. Quarterly exists
      • 3.13.5.7. Quarter top investors by company count
    • 3.13.6. UK

Chapter 4. Digital Health for Obesity Market: Component Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Component Market Share, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Digital Health for Obesity Market by Component Outlook
  • 4.5. Software
    • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6. Hardware
    • 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7. Services
    • 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Digital Health for Obesity Market: End Use Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Digital Health for Obesity Market by End Use Outlook
  • 5.5. Patients
    • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.6. Providers
    • 5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.7. Payers
    • 5.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Digital Health for Obesity Market: Regional Estimates & Trend Analysis, By Component, By End Use

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. SWOT Analysis, by Region
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.6. Singapore
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Key company market position analysis, 2024
  • 7.4. List of Companies
    • 7.4.1. WW International
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. MyFitnessPal Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Teladoc
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. FitnessKeeper
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Healthify (My Diet Coach)
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. PlateJoy
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Tempus
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Fitbit, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Noom
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. WellDoc
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Sidekick Health
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. BioAge Labs
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives